Search for: "Madhulika Vishwanathan"
Results 1 - 10
of 10
Sorted by Relevance
|
Sort by Date
31 Dec 2012, 1:52 pm
As 2012 draws to a close, Madhulika Vishwanathan brings us a concise review of the year that was [read post]
23 Dec 2012, 1:03 am
Madhulika Vishwanathan brings our attention to the Dec 18th announcement of the final version of the [read post]
29 Jan 2013, 10:44 am
Subsequently, Madhulika Vishwanathan, who’s now a part of the Spicy IP team, carried on a post [read post]
27 Jan 2013, 3:53 pm
Madhulika Vishwanathan is a registered Indian patent agent and has a Masters in Pharmacology from [read post]
28 Sep 2015, 9:58 am
rejects Pfizer patent application for Tofacitinib Spicy IP reports in a two-part blogpost by Madhulika [read post]
25 Dec 2012, 8:08 am
Another guest post in the Fellowship series followed forth, this time by Madhulika Vishwanathan, an experienced [read post]
31 Dec 2012, 11:41 pm
Next in line is a guest post by Madhulika Vishwanathan in the Spicy IP Fellowship Post Series, wherein [read post]
15 Jan 2013, 1:45 am
In light of the recent decision to issue compulsory licenses for three anti-cancer drugs, Madhulika Vishwanathan [read post]
18 Feb 2013, 12:46 am
need to re-examine the "efficacy" of the current format of the Form 27 statement.Madhulika Vishwanathan [read post]
2 Apr 2013, 10:33 am
multinational Merck’s blockbuster anti-diabetes drug Januvia (Sitagliptin phosphate), as reported by Madhulika [read post]
